Grey Healthcare Group

Share this article:
Company Profile
GHG Digital has put a stake in the ground. We offer the latest digital thinking combined with the best of every traditional discipline. We deliver in today's dynamic market while preparing your company and products for changes yet to come. We believe those who fail to act will be left to react, and that those who lead will reap the benefits of stronger consumer and physician relationships, faster market uptake, and increased sales.

GHG Digital is worldwide and fully integrated. We create multichannel programs based on medical and strategic insights that integrate the best consumer and professional advertising, branding, medical education, search optimization, and managed-care strategies in the industry. 

In 2007, GHG Digital launched PharmaForward.com, a social network for healthcare industry professionals looking to understand the rapidly changing landscape for digital marketing opportunities. In addition, GHG launched Digital Bootcamp, a training seminar for marketers who want hands-on training in the latest online strategies.

Services and Offerings
GHG Digital creates rich, single-minded strategic platforms for brands. We learn everything we can about our clients and their business and customers— whether consumer, patient, caregiver, or physician— and design integrated, multichannel marketing programs that grab attention.
  • Online Measurement and Analysis
  • Physician and Consumer Website Development
  • Search Optimization
  • Customer Generated Media (blogs, social networks, etc.)
  • Viral Marketing
  • Customer Relationship Marketing
  • Three-dimensional Scientific Visualization/Animation
  • Interactive Games and Experiential Learning
  • Multichannel Physician and Sales Rep Training
  • KOL Development Tools
  • Learning Portal and Support Services
  • Event-based Training
NovaSure Case Study
Cytyc asked GHG Digital to conceive a complete digital strategy for NovaSure, an endometrial ablation procedure for menorrhagia. The result was a comprehensive online approach to communicating with health care professionals and consumers that enabled NovaSure to measurably drive business through all digital channels. In addition, the approach enhanced and extended NovaSure's offline marketing efforts.

The integrated digital strategy included Novosure.com, a branded site for patients, NovaSure Now Network; an opt-in program designed to educate and acquire patients; Aboutheavyperiods.com, an unbranded site for patients to increase condition awareness and education, and online advertising and email campaigns that created high customer engagement.  GHG Digital also created a branded site and in-office teaching for HCPs, Synchronicity, a program for HCPs combining online and offline “best practices,” and “In-the-Know,” a personalized, turnkey program that supports post-surgery email communications from physician to patient.

Results exceeded all expectations.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...